Blog

Oct 18, 2022

Vaccines to treat cancer possible by 2030, say BioNTech founders

Posted by in categories: biotech/medical, innovation

Vaccines that target cancer could be available before the end of the decade, according to the husband and wife team behind one of the most successful Covid vaccines of the pandemic.

Uğur Şahin and Özlem Türeci, who co-founded BioNTech, the German firm that partnered with Pfizer to manufacture a revolutionary mRNA Covid vaccine, said they had made breakthroughs that fuelled their optimism for cancer vaccines in the coming years.

Comments are closed.